GoodRx Antitrust Litigation
Overview
Lockridge Grindal Nauen PLLP has filed an antitrust class action lawsuit against generic drug coupon provider GoodRx and Pharmacy Benefit Managers (PBMs) Caremark, Express Scripts, MedImpact, and Navitus. The lawsuit challenges those defendants’ conduct in artificially suppressing prescription drug reimbursement rates paid to independent pharmacies, and increasing fees charged to independent pharmacies, through the use of GoodRx-supplied prices. The defendants’ conduct has caused financial harm to independent pharmacies throughout the country.
What Does the Lawsuit Allege?
The lawsuit alleges that GoodRx and the PBM defendants conspired to suppress reimbursement rates and increase fees charged to independent pharmacies on all GoodRx-related transactions through GoodRx’s “integrated savings program.” The GoodRx integrated savings program uses GoodRx’s pricing algorithm, and real-time pricing information from PBMs, to determine prices of generic drug transactions—and to enrich GoodRx and the PBMs at the expense of independent pharmacies.
The lawsuit seeks to recover the damages incurred by independent pharmacies throughout the United States, and to put a stop to the illegal conduct of GoodRx and the PBMs in participating in the GoodRx integrated savings program. It is the first lawsuit in the U.S. challenging this conduct.
Who is Affected?
Independent pharmacies throughout the United States may have been affected by the defendants’ conduct. If your pharmacy has dispensed generic prescription medication to a patient using insurance and received reimbursement from Caremark, Express Scripts, MedImpact, or Navitus for that prescription at a GoodRx-supplied price, it may have been injured by the defendants’ conduct.
Details on the Parties and the Complaint
The plaintiff, Keaveny Drug, an independent pharmacy in Minnesota, filed the lawsuit in the U.S. District Court for the Central District of California. The lawsuit is captioned Keaveny Drug, Inc. v. GoodRx, Inc. et al. Case No. 2:24-cv-09379. The defendants are GoodRx, Inc., GoodRx Holdings, Inc., CVS Caremark Corp., Express Scripts, Inc., MedImpact Healthcare Systems, Inc., and Navitus Health Solutions, LLC.
Articles & Documents
Complaint
Contact
If you feel you may have been impacted and would like to sign up for case updates or for additional questions, please use the form or email us at info@locklaw.com.
Lockridge Grindal Nauen PLLP (“LGN”) purchases advertisements on search engines, social media platforms, and other websites. Providing information to LGN, whether in response to an advertisement or otherwise, does not create an attorney-client relationship between you and LGN. We will not agree to represent you until we (1) have determined that we do not have any conflicts that would preclude us from representing you; (2) have thoroughly evaluated your matter; and (3) have confirmed we are authorized to engage in the practice of law in the relevant jurisdiction. Nothing in LGN’s advertising or its websites is intended to suggest that its services are of a greater quality than the services that may be provided by other lawyers nor are past results a promise or suggestion of future results.